Back to search
Pulmonary Thromboendarterectomy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Thromboendarterectomy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Thromboendarterectomy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is an open label study of Riociguat in patients with continued exercise intolerance at least 6 months following pulmonary endarterectomy (PEA).
This study is being completed to determine the feasibility and acceptability of completing a home-based, structured, low-to-moderate intensity exercise training…